239 related articles for article (PubMed ID: 19087914)
1. [Gastrointestinal cytomegalovirus infections in organ transplant patients].
Péter A; Telkes G; Varga M; Járay J
Orv Hetil; 2008 Dec; 149(52):2463-70. PubMed ID: 19087914
[TBL] [Abstract][Full Text] [Related]
2. Immunocompromised hosts: perspectives in the treatment and prophylaxis of cytomegalovirus disease in solid-organ transplant recipients.
Torres-Madriz G; Boucher HW
Clin Infect Dis; 2008 Sep; 47(5):702-11. PubMed ID: 18652557
[TBL] [Abstract][Full Text] [Related]
3. [Cytomegalovirus infection in transplant recipients].
Gondo H
Nihon Rinsho; 1998 Jan; 56(1):173-8. PubMed ID: 9465685
[TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus infection following stem cell transplantation.
Einsele H; Hebart H
Haematologica; 1999 Jun; 84 Suppl EHA-4():46-9. PubMed ID: 10907466
[No Abstract] [Full Text] [Related]
5. Small bowel transplantation complicated by cytomegalovirus tissue invasive disease without viremia.
Avsar Y; Cicinnati VR; Kabar I; Wolters H; Anthoni C; Schmidt HH; Beckebaum S
J Clin Virol; 2014 Jun; 60(2):177-80. PubMed ID: 24703746
[TBL] [Abstract][Full Text] [Related]
6. Prevention and management of CMV-related problems after hematopoietic stem cell transplantation.
Zaia JA
Bone Marrow Transplant; 2002 Apr; 29(8):633-8. PubMed ID: 12180106
[TBL] [Abstract][Full Text] [Related]
7. Management strategies for cytomegalovirus infection and disease in solid organ transplant recipients.
Razonable RR
Infect Dis Clin North Am; 2013 Jun; 27(2):317-42. PubMed ID: 23714343
[TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus detected in the upper gastrointestinal tract parallel with CMV-antigenemia in liver transplant patients.
Halme L; Höckerstedt K; Salmela K; Lautenschlager I
Transplant Proc; 1999; 31(1-2):487. PubMed ID: 10083203
[No Abstract] [Full Text] [Related]
9. Clinical predictors of relapse after treatment of primary gastrointestinal cytomegalovirus disease in solid organ transplant recipients.
Eid AJ; Arthurs SK; Deziel PJ; Wilhelm MP; Razonable RR
Am J Transplant; 2010 Jan; 10(1):157-61. PubMed ID: 19889123
[TBL] [Abstract][Full Text] [Related]
10. Cytomegalovirus in hematopoietic stem cell transplant recipients: Current status, known challenges, and future strategies.
Boeckh M; Nichols WG; Papanicolaou G; Rubin R; Wingard JR; Zaia J
Biol Blood Marrow Transplant; 2003 Sep; 9(9):543-58. PubMed ID: 14506657
[TBL] [Abstract][Full Text] [Related]
11. Cytomegalovirus prophylaxis with ganciclovir and cytomegalovirus immune globulin in liver and intestinal transplantation.
Tzakis AG
Transpl Infect Dis; 2001; 3 Suppl 2():35-9. PubMed ID: 11926748
[TBL] [Abstract][Full Text] [Related]
12. Gastrointestinal cytomegalovirus disease in the immunocompromised patient.
Baroco AL; Oldfield EC
Curr Gastroenterol Rep; 2008 Aug; 10(4):409-16. PubMed ID: 18627655
[TBL] [Abstract][Full Text] [Related]
13. Fatal cytomegalovirus pneumonia after preemptive antiviral therapy in a renal transplant recipient.
Ketteler M; Preuschof L; Mertz A; Stöffler-Meilicke M; Schäfer H; Distler A; Offermann G
Clin Nephrol; 2000 Nov; 54(5):418-24. PubMed ID: 11105806
[TBL] [Abstract][Full Text] [Related]
14. Valganciclovir for the prevention and treatment of CMV in solid organ transplant recipients.
Asberg A; Rollag H; Hartmann A
Expert Opin Pharmacother; 2010 May; 11(7):1159-66. PubMed ID: 20367273
[TBL] [Abstract][Full Text] [Related]
15. Valganciclovir as treatment for cytomegalovirus disease in solid organ transplant recipients.
Len O; Gavaldà J; Aguado JM; Borrell N; Cervera C; Cisneros JM; Cuervas-Mons V; Gurguí M; Martin-Dávila P; Montejo M; Muñoz P; Bou G; Carratalà J; Torre-Cisneros J; Pahissa A;
Clin Infect Dis; 2008 Jan; 46(1):20-7. PubMed ID: 18171208
[TBL] [Abstract][Full Text] [Related]
16. Cidofovir as primary pre-emptive therapy for post-transplant cytomegalovirus infections.
Chakrabarti S; Collingham KE; Osman H; Fegan CD; Milligan DW
Bone Marrow Transplant; 2001 Nov; 28(9):879-81. PubMed ID: 11781649
[TBL] [Abstract][Full Text] [Related]
17. Does valganciclovir hydrochloride (valcyte) provide effective prophylaxis against cytomegalovirus infection in liver transplant recipients?
Jain A; Orloff M; Kashyap R; Lansing K; Betts R; Mohanka R; Menegus M; Ryan C; Bozorgzadeh A
Transplant Proc; 2005 Sep; 37(7):3182-6. PubMed ID: 16213344
[TBL] [Abstract][Full Text] [Related]
18. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.
Stocchi R; Ward KN; Fanin R; Baccarani M; Apperley JF
Haematologica; 1999 Jan; 84(1):71-9. PubMed ID: 10091394
[TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus in solid organ transplant recipients-Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice.
Razonable RR; Humar A
Clin Transplant; 2019 Sep; 33(9):e13512. PubMed ID: 30817026
[TBL] [Abstract][Full Text] [Related]
20. Preemptive therapy versus universal prophylaxis with ganciclovir for cytomegalovirus in solid organ transplant recipients.
Singh N
Clin Infect Dis; 2001 Mar; 32(5):742-51. PubMed ID: 11229841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]